Announcements Trials
Browse Landscape

Status

Completed 3050Recruiting 1142Unknown 977Terminated 458Not yet recruiting 329Active not recruiting 308Withdrawn 221Enrolling by invitation 53Suspended 28Available 7No longer available 2Approved for marketing 2

Sponsor Class

OTHER 7INDUSTRY 7

Study Type

Expanded_access 7

Sponsor

Cancer Type

Tumor-Agnostic 5Sarcoma 1NET 1Endocrine 1CNS 1

Conditions

Neoplasms 7Neuroblastoma 4Recurrence 3Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Insulinoma 2Immunologic Deficiency Syndromes 2Hypoglycemia 2Hyperinsulinism 2Hematologic Neoplasms 2Typical Teratoid Rhabdoid Tumor 1Triple Negative Local Advanced Breast Cancer 1Thyroid Nodule 1Thalassemia 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oncology Patients With Gastroparesis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Medulloblastoma 1Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 1Bone Marrow Transplantation 1Antibodies, Bispecific 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Available × OTHER × Neoplasms × Clear all
NCT06963697 2026-01-15

Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Jaime Leandro Foundation for Therapeutic Cancer Vaccines

Available
Tumor-Agnostic

Neoplasms

NCT03626285 2026-01-02

Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders

OHSU Knight Cancer Institute

Available
Tumor-Agnostic

Neoplasms

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

NCT05014607 2024-05-09

InHeVac01

University Hospital Tuebingen

Available
Tumor-Agnostic

Neoplasms

NCT05119257 2024-05-08

InHeAb01

University Hospital Tuebingen

Available
Tumor-Agnostic

Neoplasms

NCT01786850 2014-06-18

Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer

University of Roma La Sapienza

Available
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡